Tower Research Capital LLC (TRC) - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 31 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$22,000
+214.3%
2,153
+172.5%
0.00%0.0%
Q4 2017$7,000
-56.2%
790
-52.5%
0.00%0.0%
Q3 2017$16,000
-38.5%
1,664
-18.1%
0.00%
-66.7%
Q2 2017$26,000
+766.7%
2,031
+407.8%
0.00%
Q4 2016$3,000
-25.0%
400
-2.4%
0.00%
Q3 2016$4,0004100.00%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q3 2018.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders